Novartis Ag-adr (NVS) Financial News - U.S. FDA advisory meetings through Sept. 13
Novartis Ag-adr (NVS)
U.S. FDA advisory meetings through Sept. 13
2011-07-21 01:02:06
Quote: Bisphosphonates for the treatment and
prevention of osteoporosis include: FOSAMAX (alendronate
sodium) tablets and solution and FOSAMAX PLUS D (alendronate
sodium/cholecalciferol) tablets by Merck & Co Inc (MRK.N);
ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate
sodium) delayed release tablets, and ACTONEL WITH CALCIUM
(Copackaged) (risedronate sodium with calcium carbonate)
tablets by Warner Chilcott LLC (WCRX.O); BONIVA (ibandronate
sodium) tablets and injection by Roche Therapeutics Inc
(ROG.VX); RECLAST (zoledronic acid) injection by Novartis
Pharmaceuticals Corp (NOVN.VX); and the generic equivalents for
these products, if any. ARTHRITIS ADVISORY COMMITTEE DATE: Sept. 13, time TBD LOCATION: TBD CONTACT: Philip Bautista, 301-796-9001 The committee will discuss the anti-nerve growth factor
(Anti-NGF) drug class that is currently under development and
the safety issues possibly related to these drugs. The
committee will be asked to determine whether reports of joint
destruction represent a safety signal related to the Anti-NGF
class of drugs, and whether the risk-benefit balance for these
drugs favors continued development of the drugs as analgesics.(Reporting by Alina Selyukh and Anna Yukhananov; Editing by
Tim Dobbyn)...
Open whole article (external link)
Other Financial and Stock Market News concerning Novartis Ag-adr
Novartis Ag-adr Stock Summary
Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division offers prescription medicines in various therapeutic areas, including cardiovascular and metabolism; oncology; neuroscience and ophthalmics; respiratory; integrated hospital care; and other additional products. The company?s Alcon division provides various eye care products consisting of ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye, and over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; and cytotoxic products for the hospital market, as well as offer biotech manufacturing services to other companies. The company?s Vaccines and Diagnostics division provides human vaccines and blood testing and molecular diagnostics products. This division sells influenza, meningococcal, pediatric, and traveler vaccines; and nucleic acid technology blood-screening products to prevent the spread of infectious diseases. The company?s Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
